全文获取类型
收费全文 | 1260篇 |
免费 | 74篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 95篇 |
妇产科学 | 31篇 |
基础医学 | 146篇 |
口腔科学 | 33篇 |
临床医学 | 132篇 |
内科学 | 242篇 |
皮肤病学 | 21篇 |
神经病学 | 65篇 |
特种医学 | 305篇 |
外科学 | 77篇 |
综合类 | 11篇 |
预防医学 | 33篇 |
眼科学 | 20篇 |
药学 | 61篇 |
肿瘤学 | 71篇 |
出版年
2021年 | 10篇 |
2020年 | 8篇 |
2019年 | 9篇 |
2018年 | 18篇 |
2016年 | 9篇 |
2015年 | 24篇 |
2014年 | 19篇 |
2013年 | 35篇 |
2012年 | 28篇 |
2011年 | 23篇 |
2010年 | 31篇 |
2009年 | 32篇 |
2008年 | 15篇 |
2007年 | 43篇 |
2006年 | 26篇 |
2005年 | 32篇 |
2004年 | 28篇 |
2003年 | 12篇 |
2002年 | 21篇 |
2001年 | 21篇 |
2000年 | 14篇 |
1999年 | 26篇 |
1998年 | 96篇 |
1997年 | 71篇 |
1996年 | 76篇 |
1995年 | 54篇 |
1994年 | 59篇 |
1993年 | 63篇 |
1992年 | 12篇 |
1991年 | 12篇 |
1990年 | 15篇 |
1989年 | 41篇 |
1988年 | 28篇 |
1987年 | 38篇 |
1986年 | 29篇 |
1985年 | 33篇 |
1984年 | 25篇 |
1983年 | 17篇 |
1982年 | 24篇 |
1981年 | 25篇 |
1980年 | 30篇 |
1979年 | 9篇 |
1978年 | 19篇 |
1977年 | 18篇 |
1976年 | 24篇 |
1975年 | 14篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1970年 | 3篇 |
1968年 | 3篇 |
排序方式: 共有1345条查询结果,搜索用时 31 毫秒
101.
IB McIntosh MB ChB KG Power PhD RJ Simpson MRCPsych 《International journal of clinical practice》1994,48(3):118-121
SUMMARY The psychological impact of an epidemiological study of benign prostatic hypertrophy (BPH) was assessed in a representative sample of practice list patients. Of the 889 men completing a general health self-report questionnaire previously validated in a screening programme, 75% knew nothing of problems of the prostate, and 84.5% were not at all worried about prostate problems prior to commencement of the study. Receiving the letter of invitation and the procedures neither increased nor reduced anxiety levels for 69% and 70% respectively. In the 227 men referred to hospital for further investigation the procedure increased anxiety in 28%, decreased anxiety in 20%, and had no effect on the remainder. The sample of 137 (16%) men who, prior to interview, were in some way worried about problems of the prostate had significantly more urinary tract symptoms than those who were not at all worried about prostatic problems. Despite being worried about prostatic problems and having significant urinary symptoms, this group was no more likely to have attended a GP for investigation and/or treatment. Results are discussed in relation to the possible psychological effects of general health screening and the reluctance of men to attend for consultation despite awareness and concern regarding urinary symptomatology. 相似文献
102.
The inter‐rater reliability between nurse‐assessors clinically assessing infection of chronic wounds using the WUWHS criteria
下载免费PDF全文
![点击此处可从《International wound journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jacqueline JHHM Vestjens Armand ALM Rondas Richard RJ White Samantha SL Holloway 《International wound journal》2018,15(1):8-15
The aim of this study was to determine the inter‐rater reliability between one expert‐nurse and four clinical‐nurses who were asked to clinically assess infection of chronic wounds by using the World Union of Wound Healing Societies (WUWHS) criteria. A quasi‐experimental design was used to collect the data. In comparison to phase 1 in which ‘open questions’ were asked, in phase 2 a pre‐printed form (checklist) was introduced. In both phases, 55 chronic wounds were clinically assessed. For each WUWHS criterion the inter‐rater reliability of signs and symptoms was expressed by Cohens Kappa (κ). A substantial agreement (κ ≥ 0·6) was considered as adequate. In both phases pocketing (p < 0·02), and erythema (p < 0·004) scored statistically significant results. Phase 2 showed higher inter‐rater agreements compared with phase 1 (three substantial agreements (easily bleeding/friable granulation tissue, delayed healing, increasing exudate), an almost perfect‐ and a perfect agreement for malodour and pain, respectively. According to the results it can be concluded that the clinical assessment of infection of chronic wounds may be better supported by a pre‐printed form than making use of an ‘open questions’ form. To provide this with a higher level of evidence, there is need for more well conducted studies. 相似文献
103.
Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions 总被引:2,自引:0,他引:2
Mills IH; Park GR; Manara AR; Merriman RJ 《QJM : monthly journal of the Association of Physicians》1998,91(7):493-503
We have previously shown that eating disorders are a compulsive behaviour
disease, characterized by frequent recall of anorexic thoughts. Evidence
suggests that memory is a neocortical neuronal network, excitation of which
involves the hippocampus, with recall occurring by re-excitement of the
same specific network. Excitement of the hippocampus by glutamate-NMDA
receptors, leading to long-term potentiation (LTP), can be blocked by
ketamine. Continuous block of LTP prevents new memory formation but does
not affect previous memories. Opioid antagonists prevent loss of
consciousness with ketamine but do not prevent the block of LTP. We used
infusions of 20 mg per hour ketamine for 10 h with 20 mg twice daily
nalmefene as opioid antagonist to treat 15 patients with a long history of
eating disorder, all of whom were chronic and resistant to several other
forms of treatment. Nine (responders) showed prolonged remission when
treated with two to nine ketamine infusions at intervals of 5 days to 3
weeks. Clinical response was associated with a significant decrease in
Compulsion score: before ketamine, mean +/- SE was 44.0 +/- 2.5; after
ketamine, 27.0 +/- 3.5 (t test, p = 0.0016). In six patients
(non-responders) the score was: before ketamine, 42.8 +/- 3.7; after
ketamine, 44.8 +/- 3.1. There was no significant response to at least five
ketamine treatments, perhaps because the compulsive drive was
re-established too soon after the infusion, or because the dose of opioid
antagonist, nalmefene, was too low.
相似文献
104.
自美国国家骨髓库(NMDP)开展第一例无关供者移植以来,至今已有20年.NMDP目前的库容量已逾700万,已为6大洲提供了30 000多份无关供者造血干细胞.这一辉煌成就是美国国家骨髓库600多名工作人员共同努力的结果,同时也得益于广泛的国际合作,包括171个移植中心,73个供者中心,24个脐血库,97个骨髓采集中心,91个血液净化中心,26个HLA分型实验室和26个合作供者登记处.本文回顾了美国国家骨髓库的历史,阐述了20年来移植病人、移植物来源和预处理方案几方面的主要变化趋势. 相似文献
105.
Growth hormone therapy for protein catabolism 总被引:5,自引:0,他引:5
GH and IGF-I have shown remarkable consistency of effect in a wide range of
catabolic conditions. Doses of around 10 IU/m2/day of GH and 80
micrograms/kg/day of IGF-I over short periods of time can improve net
protein synthesis and preserve lean body mass. Most studies have reported
metabolic endpoints, but favorable clinical effects have included decreased
hospital stay and mortality in burns, improved respiratory muscle function
in COAD, preserved grip strength post- operatively, and improvements in
cardiac and bowel failure. Adverse effects of GH treatment are uncommon and
usually related to glycaemic control. GH and IGF-I have differential
effects on insulin concentrations--increasing or decreasing concentrations,
respectively. The hypoglycaemic effects of IGF-I are dependent on route of
administration and are avoided by subcutaneous delivery. Occasional
patients have needed to discontinue GH treatment due to hyperglycaemia,
although the anabolic action of GH may be partially mediated by increased
insulin levels. The co-administration of GH and IGF-I has theoretical
advantages by both increasing IGF binding-protein concentrations and
balancing glycaemic control. An initial study with combination therapy in
calorically-restricted volunteers has shown anabolic effects greater than
with either agent alone. This approach requires further study in catabolic
patients. There is a need for large, well-designed trials with clinical
rather than purely metabolic end-points, and some of these are already
underway. Should these studies confirm the early findings, financial
considerations will become paramount, although it remains possible that
treatment may be self-financing if lengths of hospital admissions are
shortened.
相似文献
106.
Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice 总被引:1,自引:0,他引:1
Scott RJ; Aitchison WR; Barker PR; McLaren GI 《QJM : monthly journal of the Association of Physicians》1996,89(8):613-622
We investigated the efficacy, safety and tolerability compared with placebo
of a second dose of oral sumatriptan 100 mg in 1349 general practice
patients who had already treated a moderate or severe migraine headache
with 100 mg sumatriptan 4 h earlier. Headache was relieved by the first
sumatriptan dose in about 70% of patients, but the second dose did not
produce significantly more relief than placebo, either in nonresponders or
in the group as a whole, nor did it reduce other symptoms (photophobia,
nausea, vomiting, etc,) at 8 h, or influence the incidence of headache
recurrence. The drug was well-tolerated, and a further single dose was
effective in treating recurrence after initial relief. A single 100 mg dose
of sumatriptan is an effective acute treatment for migraine. A second dose
should be reserved for treating headache recurrence.
相似文献
107.
108.
The efficacy of subcutaneous recombinant human erythropoietin (rhEPO) (500 U/kg; administered twice a week during the 3 weeks before surgery) in the recovery of preoperative hemoglobin concentrations within a 3- week period was studied in 40 patients, each of whom donated 2 units (900 mL) of blood for their own use before total hip replacement surgery. Twenty autologous blood donors received rhEPO (EPO group) and 20 were not treated (control group). The initial hemoglobin concentration (14.0 +/− 1.0 g/dL [140 +/− 10 g/L]) was completely recovered before surgery (14.0 +/− 1.6 g/dL [140 +/− 16 g/L]) in the EPO group, while a decrease from 13.8 +/− 1.1 to 12.2 +/− 1.3 g per dL (138 +/− 11 to 122 +/− 13 g/L) was observed in the control group. The preoperative reticulocyte count showed more than sixfold increase in the EPO group, whereas a twofold to threefold increase was found in the control group. Serum ferritin concentration fell to 42 +/− 29 micrograms per L in the EPO group and to 54 +/− 35 micrograms per L in the control group. The postoperative serum erythropoietin concentration in the EPO group was significantly lower than that in the control group, but it did not differ from the pretreatment value and was attended by a higher hemoglobin concentration after surgery. Only transient flu-like symptoms were mentioned by patients who were treated with rhEPO. Changes in blood pressure or platelet count or other adverse events were not observed.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
109.
Two patients are described in whom clinically significant red blood cell alloantibodies could be demonstrated only by in vivo 51chromium (51Cr) survival studies. The first patient had experienced a severe delayed hemolytic transfusion reaction to four units of crossmatch compatible blood. Serial phenotype studies suggested the presence of a serologically undetectable anti-c (hr') antibody. 51Cr survival of c- positive red blood cells was one per cent at 24 hours, while survival of c-negative red blood cells was 80 per cent at 24 hours. The second patient had multiple red blood cell alloantibodies. An anti-c antibody was suspected but could not be convincingly demonstrated by in vitro techniques. 51Cr survival of c-positive red blood cells, however, was 57 per cent at 24 hours and 17 per cent at 48 hours. 51Chromium red blood cell survival studies should be considered whenever an unexplained hemolytic transfusion reaction occurs, or when an expected red blood cell alloantibody cannot be demonstrated by in vitro laboratory studies. 相似文献
110.